Naoumova RP - Search Results

1

Use of cholesterol precursors to assess changes in cholesterol synthesis under non-steady-state conditions.

Pfohl M, Naoumova RP, Kim KD, Thompson GR. Pfohl M, et al. Among authors: naoumova rp. Eur J Clin Invest. 1998 Jun;28(6):491-6. doi: 10.1046/j.1365-2362.1998.00321.x. Eur J Clin Invest. 1998. PMID: 9693942

2

Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.

Naoumova RP, Cummings MH, Watts GF, Rendell NB, Taylor GW, Sönksen PH, Thompson GR. Naoumova RP, et al. Eur J Clin Invest. 1996 Apr;26(4):332-40. doi: 10.1046/j.1365-2362.1996.138285.x. Eur J Clin Invest. 1996. PMID: 8732493 Clinical Trial.

3

Upregulation of cholesterol synthesis after acute reduction of low density lipoprotein by apheresis in normocholesterolaemic subjects: evidence for a threshold effect.

Pfohl M, Naoumova RP, Neuwirth C, Sussekov A, Smykowski J, Rendell NB, Taylor GW, Seif FJ, Thompson GR. Pfohl M, et al. Among authors: naoumova rp. Atherosclerosis. 1997 Dec;135(2):257-62. doi: 10.1016/s0021-9150(97)00173-1. Atherosclerosis. 1997. PMID: 9430376

4

Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway.

Naoumova RP, O'Neill FH, Dunn S, Neuwirth CK, Taylor GW, Axelson M, Thompson GR. Naoumova RP, et al. Eur J Clin Invest. 1999 May;29(5):404-12. doi: 10.1046/j.1365-2362.1999.00475.x. Eur J Clin Invest. 1999. PMID: 10354197 Clinical Trial.

5

Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy.

Pfohl M, Naoumova RP, Klass C, Knisel W, Jakober B, Risler T, Thompson GR. Pfohl M, et al. Among authors: naoumova rp. J Lipid Res. 1994 Nov;35(11):1946-55. J Lipid Res. 1994. PMID: 7868973 Free article. Clinical Trial.

6

Role of cholesterol in regulating apolipoprotein B secretion by the liver.

Thompson GR, Naoumova RP, Watts GF. Thompson GR, et al. Among authors: naoumova rp. J Lipid Res. 1996 Mar;37(3):439-47. J Lipid Res. 1996. PMID: 8728309 Free article. Review.

7

Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin.

Naoumova RP, Dunn S, Rallidis L, Abu-Muhana O, Neuwirth C, Rendell NB, Taylor GW, Thompson GR. Naoumova RP, et al. J Lipid Res. 1997 Jul;38(7):1496-500. J Lipid Res. 1997. PMID: 9254075 Free article. Clinical Trial.

8

Cholesterol synthesis is increased in mixed hyperlipidaemia.

Naoumova RP, Kim KD, Neuwirth C, Niththyananthan S, Rendell NB, Taylor GW, Thompson GR. Naoumova RP, et al. Biochim Biophys Acta. 1998 Nov 2;1394(2-3):146-52. doi: 10.1016/s0005-2760(98)00103-9. Biochim Biophys Acta. 1998. PMID: 9795192

9

Novel lipid-regulating drugs.

Thompson GR, Naoumova RP. Thompson GR, et al. Among authors: naoumova rp. Expert Opin Investig Drugs. 2000 Nov;9(11):2619-28. doi: 10.1517/13543784.9.11.2619. Expert Opin Investig Drugs. 2000. PMID: 11060824 Review.

10

Treatment with atorvastatin alters the ratio of interleukin-12/interleukin-10 gene expression [corrected].

Naoumova RP, Patel DD, O'Neill FH, Thompson GR, Knight BL. Naoumova RP, et al. Eur J Clin Invest. 2003 Jan;33(1):88-91. doi: 10.1046/j.1365-2362.2003.01105.x. Eur J Clin Invest. 2003. PMID: 12492458 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page